483
Toyobo Co. Ltd.Toyobo Co. Ltd. – FDA 483, Jan 15, 2018
Record Details
Toyobo Co., Ltd. Otsu Pharmaceuticals Plant in Otsu-Shi, Japan, was cited for significant deficiencies during an FDA inspection. Observations included widespread data integrity issues in laboratory records and ineffective corrective actions, as well as critical failures in aseptic processing area disinfection and sterilization validation. The firm also lacked adequate procedures for computer software changes and equipment cleanliness inspections.
View Company Profile
ID · 6a5fa569-95eb-48c0-a9b9-070ef96fa235
Other documents for Toyobo Co. Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.